The impact of symptom distress on health-related quality of life in liver cancer patients receiving arterial chemoembolization: the mediating role of hope
Abstract Background Trans-hepatic arterial chemoembolization (TACE) is a treatment option for liver cancer patients. It can prolong patients’ survival but can also cause symptom distress. Symptom distress (SDs) can directly impact quality of life (QOL) and may indirectly influence QOL by lessening h...
Main Authors: | Nan-Yan Chen, Kang-Hua Chen, Yi-Wen Wang, Hsiu-Hsin Tsai, Wei-Chen Lee, Li-Chueh Weng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-022-02529-x |
Similar Items
-
Safety and Efficacy of Liver Venous Deprivation Following Transarterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma
by: Sy TV, et al.
Published: (2023-05-01) -
The update on transcatheter arterial chemoembolization using drug-eluting beads: Optimization for best response
by: Jung Suk Oh, et al.
Published: (2021-10-01) -
Comparison of the Efficacy and Safety of Transarterial Chemoembolization Plus Microwave Ablation versus Surgical Resection in Patients with Solitary Large Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
by: Zhang Y, et al.
Published: (2022-12-01) -
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
by: Jae Seung Lee, et al.
Published: (2020-01-01) -
Trans-Arterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single Tertiary Care Institute Experience
by: Parvez Ahmed, et al.
Published: (2023-07-01)